HYBIO PHARMACEUTICAL CO., LTD

About HYBIO PHARMACEUTICAL CO., LTD

Hybio is a hi-tech enterprise specialized in the R&D and manufacturing of diverse peptide products. Founded in 1998, we have grown up to be a leading peptide pharmaceutical company and the first going public in China (2011, stock code 300199). We offer a full range of peptide products (API & FDF) and services (CRO & CDMO). Our peptide FDFs are mainly sold in Chinese domestic market, and peptide APIs are mostly supplied worldwide.
Hybio Headquarters in Shenzhen has passed local & national NMPA GMP inspection for over 90 ti...

Certifications
  • CN
  • 2015
    On CPHI since
  • 3
    Certificates
  • 500 - 999
    Employees
Company types
Manufacturer/Innovator
Primary activities
API Producer
Contact info
Meet us at

CPHI & PMEC China 2024

Shanghai New International Expo Center
19 June 2024 - 21 June 2024

CPHI Milan 2024

Fiera Milano, Italy
08 Oct 2024 - 10 Oct 2024

Products from HYBIO PHARMACEUTICAL CO., LTD (5)

  • Etelcalcetide

    Product Etelcalcetide

    Hybio offers a wide range of peptide APIs. Contact us for more information.
  • Semaglutide

    Product Semaglutide

    Hybio Pharmaceutical Co., Ltd. offers a wide range of pharmaceutical products which includes calcitonin(salmon). It belongs to active pharmaceutical ingredient category. Contact us for more information.
  • Carbetocin

    Product Carbetocin

    Hybio Pharmaceutical Co., Ltd. offers wide range of pharmaceutical products which includes carbetocin. It belongs to active pharmaceutical ingredient category. Contact us for more information.
  • Cetrorelix

    Product Cetrorelix

    Hybio Pharmaceutical Co., Ltd. offers wide range of pharmaceutical products which includes cetrorelix. It belongs to active pharmaceutical ingredient category. Contact us for more information.
  • Degarelix

    Product Degarelix

    Hybio offers a wide range of peptide APIs. Contact us for more information.